Article de revue
Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants
The use of 4 different PCV13 immunization schedules in healthy term infants resulted in no statistically significant differences in antibody levels after the booster dose for almost all serotypes. The choice of PCV schedule will require a balance between the need for early protection and maintaining protection between the primary series and the booster.
Auteurs
Langues
- Anglais
Année de publication
2013
Journal
JAMA
Volume
9
Type
Article de revue
Catégories
- Prestation de services
Maladies
- Infection à pneumocoque
Pays
- Pays-Bas
Organisations
- Organisation Mondiale de la Santé (OMS)
Mots-clés
- New vaccine introduction
Régions de l'OMS
- Région européenne